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The Sendai virus C proteins, C9, C, Y1, and Y2, are a nested set of four independently initiated carboxy-coterminal proteins
encoded on the P mRNA from an alternate reading frame. Together the C proteins have been shown to inhibit viral
transcription and replication in vivo and in vitro and C9 binds the Sendai virus L protein, the presumed catalytic subunit of the
viral RNA polymerase. To identify amino acids within the C9 protein that are important for binding L, site-directed mutagenesis
of the gstC9 gene was used to change conserved charged amino acids to alanine, generating nine mutants. Additionally, a
tenth natural mutant, gstF170S, was also constructed. Six of the gstC9 mutants, primarily in the C-terminal half of C9, exhibited
a defect in the ability to bind L protein. The mutants were assayed for their effect on in vitro transcription and replication from
the antigenomic promoter, and the data suggest in all but one case a direct correlation between the ability of C to bind L and
to inhibit these steps in RNA synthesis. Further studies with two nonfusion C mutants showed that this correlation was
specifically due to the C9 portion, and not the gst portion, of the fusion proteins. To study their individual functions, each of
the four C proteins was fused downstream of glutathione S-transferase. The gstC9, gstC, gstY1, and gstY1 fusion proteins
were all able to bind L protein and to inhibit viral mRNA and (1)-leader RNA synthesis, and antigenome replication in vitro.
In addition, the nonfusion C, Y1, and Y2 proteins all inhibited transcription. The inhibition of (1)-leader RNA and mRNA
synthesis by wt C proteins (nonfusion) showed nearly identical dose-response curves, suggesting that inhibition occurs early
in RNA synthesis. © 2001 Academic Press
INTRODUCTION
Sendai virus is a paramyxovirus with a single-
stranded, (2)-sense, nonsegmented RNA genome of
;15 kb (Lamb and Kolakofsky, 1996). The RNA genome is
fully encapsidated by the virus-encoded NP protein, and
it is this ribonucleoprotein complex, or nucleocapsid,
which serves as the template for all viral RNA synthesis.
The viral RNA-dependent RNA polymerase which com-
prises two virus-encoded subunits, the phosphoprotein
[P, 568 amino acids (aa)] and large (L, 2228 aa) proteins
(Horikami et al., 1992; Parks, 1994), is associated with the
ucleocapsid and packaged into virions. It is thought that
he L protein possesses all the catalytic functions nec-
ssary for RNA synthesis and mRNA processing (Gotoh
t al., 1989; Horikami et al., 1992; Hunt and Hutchinson,
1993). Coexpression of P and L is necessary for poly-
merase complex formation, where P protein is responsi-
ble for the folding and stabilization of L (Horikami et al.,
1992). The polymerase contacts the nucleocapsid tem-
plate through the P subunit (Horikami et al., 1992;
Horikami and Moyer, 1995; Ryan and Portner, 1990). The
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96Sendai virus polymerase initiates transcription precisely
at the 39 end of the genome, producing first a 55-nucle-
otide (nt) (1)-sense leader (le1) RNA, followed by the
monocistronic mRNAs in the linear order of the genome:
39-le1-NP-P/C/V-M-F-HN-L-59 (Lamb and Kolakofsky,
1996). Viral replication is also carried out by the viral
polymerase producing a full-length, antigenomic (1)-
sense replication intermediate, which then serves as the
template for subsequent (2)-sense genome synthesis.
During replication, the synthesis of nascent RNA is cou-
pled to its encapsidation by NP protein, resulting in
nuclease-resistant genome and antigenome RNAs. The
copyback defective interfering particle, DI-H, used here
for replication studies has a 1410-nt genome. This tem-
plate has two copies of the antigenomic promoter and
therefore measures replication from only one of the two
wild-type promoters.
The Sendai C proteins are a nested set of four car-
boxy-coterminal proteins (C9, C, Y1, and Y2), which are all
translated from the P mRNA. The start codons for these
four proteins are all in the 11 reading frame relative to
the P ORF, where C9 has an unusual ACG translation
start site (Fig. 1A) (Curran and Kolakofsky, 1988; Gupta
and Patwardhan, 1988). The translation of C9, P, and C is
thought to occur in a ribosome scanning-dependent
manner (Curran and Kolakofsky, 1988, 1989), while trans-
lation of Y1 and Y2 appears to be scanning-independent
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Latorre et al., 1998b). The C protein is the major species
expressed in infected cells. The C proteins function to
downregulate all viral RNA synthesis. The initial studies
showed that abrogation of all C protein expression from
a plasmid containing the P/C gene resulted in an in-
crease of viral mRNA synthesis in vitro, and reexpression
of C from a second plasmid decreased mRNA synthesis
(Curran et al., 1992). Further studies revealed that the C
proteins could inhibit internally deleted DI and wild-type
(wt) genome replication in vivo, as well as copyback DI-H
replication in vitro, but had no effect on DI-H replication
in vivo (Cadd et al.,1996). Tapparel et al. (1997) then
showed that inhibition of DI-H replication in vivo de-
pended on the ratio of C proteins to template and the
regulatory effect of the C proteins appeared to be pro-
moter-specific.
The Sendai C proteins have been shown to play a role
in viral pathogenesis. Studies of the avirulent Ohita-
MVC11 strain (SVMVC), in which the attenuating mutation
was identified as F170S in the C ORF, showed virus titers
equivalent to the parental strain Ohita-M (SeVM) only for
the first day of infection in mouse lung and was then
cleared, while SeVM titers continued to increase for ;5
days (Garcin et al., 1997; Itoh et al., 1997). In tissue
culture cells, rSV-CMVC infection gave increased viral rep-
lication and transcription (Garcin et al., 1997). In addition,
FIG. 1. P and C protein coding strategy and C9 mutants generated by
site-directed mutagenesis. (A) A schematic of the N-terminus of the P
mRNA, showing the four C protein translational start sites relative to the
P protein start site. The lengths of the proteins are indicated inside the
boxes. (B) Amino acid sequence of the Sendai virus C proteins, with the
start sites for C9, C, Y1, and Y2 indicated above the sequence. Amino
acids changed to alanine are indicated in bold and underlined with the
name of each mutant indicated below the sequence. The F170S mutant
contained a serine substitution.
VIRAL RNA SYNTHESIS INHplasmid-expressed C protein containing the F170S
change was found to have lost its ability to inhibit inter-
o
pnally deleted DI replication in cell culture and in vitro
(Cadd et al., 1996). Thus the inhibition of RNA synthesis
is somehow involved in pathogenesis. Viable recombi-
nant Sendai virus (rSeV) C protein knock-out viruses
have also been rescued and used to further investigate
the effect of the C proteins on Sendai pathogenesis
(Kurotani et al., 1998; Latorre et al., 1998a). A virus ex-
pressing no C proteins, 4C2, was critically impaired for
growth, again suggesting that the C proteins were nec-
essary for viral reproduction (Kurotani et al., 1998). The C
proteins have also been shown to inhibit the antiviral
action of interferons (Garcin et al., 1999; Gotoh et al.,
1999) and recently to be necessary for the assembly of
the major structural proteins into virus particles (Hasan
et al., 2000).
Horikami et al. (1997), using a glutathione S-trans-
ferase-(gst)–C9 fusion protein, showed that gstC9 specif-
ically bound the L protein, but not the other viral proteins,
P or NP, involved in RNA synthesis. Furthermore, P bind-
ing to L did not interfere with C binding to L, suggesting
that the binding sites of the two proteins on the L protein
are distinct. GstC9, similar to the set of C proteins, inhib-
ited Sendai mRNA synthesis in a dose-dependent man-
ner. Therefore, we proposed that C downregulated RNA
synthesis directly through contact with the L subunit of
the viral polymerase. To investigate the mechanism of
inhibition, we wanted to identify amino acids necessary
for C binding to L. A clustered charged-to-alanine mu-
tagenesis strategy was utilized to construct nine mutants
in the C9 portion of the gstC9 fusion protein. This method
would hopefully maximize the likelihood of producing
stable mutant proteins with amino acid changes on the
surface of the protein (Bass et al., 1991; Cunningham and
ells, 1989). Conserved, charged amino acids to be
argeted for mutagenesis were identified by alignment of
protein sequences of members of the paramyxovirus
enus. We have shown a direct correlation between the
bility of the wild-type and mutant C proteins to bind L
nd to inhibit viral transcription and antigenome replica-
ion.
RESULTS
utant C9 proteins show a spectrum of L binding
henotypes
To identify amino acids in the C proteins that are
mportant for binding to the L protein, as described under
aterials and Methods, we constructed charged-to-ala-
ine mutations throughout C9 in gstC9 (Fig. 1B), as well
s the mutation F170S (F181S in the C9 ORF), which
nhibited C function (Cadd et al., 1996; Garcin et al.,
997). The mutants were tested for their ability to form a
omplex with L by the ability of L to cobind with gstC9 to
lutathione–Sepharose beads. No plasmids (2) or the wt
97BY SENDAI C PROTEINSr mutant gstC9 plasmids together with the L and P
lasmids were transfected into VVT7-infected cells and
o
e
ANDthe cells labeled with Express-[35S]. P was included in
these experiments to stabilize the L protein (Horikami et
al., 1997). Immunoprecipitation of a portion of the cyto-
plasmic cell extracts showed that all mutant gstC9 pro-
teins were expressed at levels similar to wt gstC9 (Fig.
2A). The L and P proteins in each sample were similarly
expressed except the level of L protein was decreased in
lane 3 due to a gel defect which was not seen in repeat
experiments. As the positive control, L bound to wt gstC9
selected on glutathione beads and P was cobound be-
cause it was complexed to the L protein (Fig. 2B, lane 2
and Horikami et al., 1997). The other bands were non-
FIG. 2. Complex formation between mutant gstC9 proteins and the L
protein. VVT7-infected cells were mock transfected (2) or transfected
with plasmids encoding the P, L, and the indicated wt or mutant gstC9
proteins. The cells were labeled with Express-[35S] and cytoplasmic
extracts were (A) immunoprecipitated with a-L, a-P, and a-gst antibod-
ies or (B) incubated with glutathione–Sepharose beads as detailed
under Materials and Methods. The immunoprecipitated and bead-
bound proteins were analyzed by SDS–PAGE. The positions of the L, P,
and gstC9 mutant proteins are indicated. The background binding of L
to the gst portion of the fusion protein was ,2% (Horikami et al., 1997).
98 GROGANspecifically bound to the glutathione beads (Fig. 2B, lane
1). To quantitate the L and gstC9 interaction, the levels ofL and the fusion proteins bound to beads were first
normalized for the amounts of protein expression, as
determined by immunoprecipitation. Mutants that re-
tained 83–100% of the ability to bind L, compared to wt
gstC9, included the following: gstC91, gstC93, gstC97, and
gstC99 (Fig. 2B, lanes 4, 6, 10, and 12; Table 1). Mutants
that showed significantly reduced L binding (51–19%)
included the following: F170S, gstC92, gstC94–6, and
gstC98 (Fig. 2B, lanes 3, 5, 7–9, and 11; Table 1). The
amount of P protein cobound also decreased corre-
spondingly when gstC9:L binding was diminished as
expected. These data show that over half of the muta-
tions gave significantly decreased L binding, although no
mutation completely abolished binding. Furthermore, the
amino acids important for binding L were scattered,
predominantly within the C-terminal half of C9, suggest-
ing that the L-binding site consists of noncontiguous
amino acids, although it is possible that some of the
mutations may have had long range, rather than direct,
effects on binding.
Inhibition of in vitro viral RNA synthesis by mutant
gstC9 proteins correlates with L binding
To relate complex formation with L to the functional
activity of the C9 protein, the wt and mutant gstC9 pro-
teins were tested for their ability to inhibit Sendai virus
mRNA synthesis in vitro. VVT7-infected cells were either
mock transfected (2) or transfected with the wt L and P,
and wt or mutant gstC9 plasmids, and cell extracts were
TABLE 1
Summary of L Binding and RNA Synthesis Inhibition
by the gstC9 Mutants
Mutant L binding (%)a
Inhibition (%)b
mRNA Replication
none 0 0 0
gstC9 (wt) 100 82 93
gstC91 89 88 NDc
gstC92 19 0 30
gstC93 100 30 0
gstC94 38 41 ND
gstC95 33 36 0
gstC96 37 42 ND
gstC97 90 88 94
gstC98 38 40 ND
gstC99 83 78 ND
gstF170S 51 32 6
a L binding of the mutants was expressed as a percentage of binding
f wt gstC9 to L as 100%, where the data are the average of four to six
xperiments as in Fig. 4 with a deviation of 615%.
b mRNA synthesis and DI-H replication in the absence of any gstC9
protein was set as 100% synthesis, expressed as 0% inhibition, and the
data are the average of four to six experiments with a deviation of
MOYER610%.
c ND, not determined.
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passayed for the ability to support mRNA synthesis from
purified wt RNA-NP template. The Sendai P–L polymer-
ase complex, in the absence of gstC9 but the presence of
st, synthesized full-length NP and P transcripts which
omigrate on this gel (Fig. 3A, lanes 2 and 10), whereas
n the absence of viral proteins no RNA synthesis oc-
urred (lanes 1 and 9). The addition of wt gstC9 inhibited
RNA synthesis by the viral polymerase between 70 and
5%; the average of multiple experiments was 82% (Fig.
A, lanes 3 and 11; Table 1). Mutants that retained most
f the ability to inhibit mRNA synthesis included gstC91
nd gstC97 (Fig. 3A, lanes 4 and 14) and also still bound
(Table 1). Mutant gstC99 retained 83% of the binding to
and showed a corresponding inhibition of 78% (Fig. 3A,
ane 16; Table 1). Mutants that had a significant loss of
nhibitory activity (on average 32–42%) included the fol-
owing: gstC94, gstC95, gstC96, gstC98, and F170S (Fig.
A, lanes 6–8, 12, 13, and 15; Table 1), which correlated
ith their reduced binding to L. GstC92 gave no inhibition
f RNA synthesis (Fig. 3A, lane 5), which correlated with
he lowest L binding. The mutant protein gstC93 is inter-
sting since it retained full binding to L but only inhibited
ranscription by 30% (Fig. 3A, lane 6). This mutant thus
eparates the binding and inhibitory functions of C9.
mmunoblot analyses on portions of the extracts used for
ranscription showed that P and the wt or mutant gstC9
roteins were all expressed at similar levels (Fig. 3B), so
he differential activities are not a result of different
rotein concentrations. The upper band of the bottom
lot appearing in all lanes including mock is a vaccinia
FIG. 3. Effect of mutant gstC9 proteins on in vitro transcription. (A) VV
gst plasmids, or wt P, L, and the wt or mutant gstC9 plasmids as ind
template in the presence of [a-32P]CTP as discussed under Materials
phoresis. The position of the NP and P transcripts is indicated. (B)
antibodies. The positions of the P and gstC9 proteins are indicated.
VIRAL RNA SYNTHESIS INHrotein that cross-reacted with the a-gst antibody. No
ntibody is available to detect L protein in an immuno-lot; however, radiolabeling experiments showed that L
xpression was similar in each sample (Fig. 2A). Thus
utagenesis of the C9 amino acids resulted in a spec-
rum of phenotypes ranging from full retention to nearly
omplete loss of inhibitory activity. Importantly, the data
ndicate a direct correlation in 9 of 10 cases between the
bility of gstC9 to bind L and the amount of inhibition of
iral transcription (Table 1).
To extend this analysis, selected gstC9 mutants with a
ange of activities were also tested for their ability to
nhibit the replication of polymerase-free DI-H template
n vitro, which measures the activity of the antigenome
romoter. With NP, P, and L in the absence of gstC9 but
the presence of gst, the replication of DI-H occurred (Fig.
4A, lanes 2 and 7), whereas in the absence of any viral
proteins, no product was synthesized (lanes 1 and 6). Wt
gstC9 and gstC97, which both gave nearly complete inhi-
bition of transcription, also similarly inhibited DI-H repli-
cation greater than 90% (Fig. 4A, lanes 3, 8, and 11; Table
1). Mutant protein gstC92 did give some inhibition of
replication (30%) (Fig. 4A, lane 4), although it did not
inhibit transcription. The mutants gstF170S, gstC93, and
gstC95, which inhibited transcription by 30–36%, did not
inhibit replication at all (Fig. 4A, lanes 5, 9, and 10; Table
1). Thus the loss of inhibition was more evident in repli-
cation than transcription. Immunoblot analyses showed
that the proteins were similarly synthesized (Fig. 4B).
These data indicate that the correlation between gstC9
binding L and the ability to inhibit transcription can be
cted cells were mock transfected (2) or transfected with wt P, L, and
Cytoplasmic extracts were prepared and incubated with wt RNA-NP
ethods. RNA transcripts were isolated and analyzed by gel electro-
oblot analyses on extracts in (A) using a-P (top) and a-gst (bottom)
99BY SENDAI C PROTEINST7-infe
icated.
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IBITIONextended to include the inhibition of antigenome replica-
tion as well.
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imilar to the mutant gstC9 proteins
We previously showed that the gst portion of the wt
stC9 fusion protein did not affect its inhibitory activity
Horikami et al., 1997). As a further control, plasmid
encoding just the gst protein was included in transfec-
tions with P and L (and NP) when assaying transcription
(or replication) in the absence of gstC9 protein for all
activity assays reported here and gst had no effect on
RNA synthesis. However, we wanted to further ensure
that the phenotypes observed with the gstC9 mutants
were reflective of the mutated C protein and not due to
any pleiotropic effect of the gst portion. Therefore, two
nonfusion C mutant proteins, C2 and F170S, which were
reduced in binding and inhibition in gst-fusion form, were
constructed in the plasmid pGEM-C as described under
Materials and Methods. In contrast to the experiments
where only one gstC9 fusion protein was synthesized, all
four wt or mutant C proteins are expressed from this
plasmid. These mutant forms of C were no longer rec-
ognized by the a-C antibody in an immunoblot analysis;
therefore, an in vitro coupled transcription–translation
ystem was used to determine the amounts of plasmids
ecessary for equivalent wtC, C2, and F170S protein
xpression (data not shown). C2 and F170S were then
ested for inhibition of various aspects of viral RNA syn-
hesis as described above. Compared to mRNA synthe-
is in the absence of any C protein, wtC inhibited tran-
cription by the viral polymerase by 90% (Fig. 5A), as
bserved previously (Curran et al., 1992; Horikami et al.,
997). In the presence of C2 or F170S, inhibition was 5
nd 28%, respectively (Fig. 5A), results nearly identical to
FIG. 4. Effect of selected mutant gstC9 proteins on in vitro DI-H repli
lasmids encoding the wt NP, P, L, and gst proteins (wt), or with thos
ytoplasmic extracts were prepared, incubated with polymerase-free D
urified nucleocapsid RNA analyzed by gel electrophoresis as discuss
B) Immunoblot analyses on extracts in (A) with a-P and a-SV (top) a
ndicated.
00 GROGANhe level of inhibition observed with the gst-fusion forms
f these mutants. A similar pattern of inhibition was
a
tbserved for in vitro DI-H replication (Fig. 5B). The wtC
rotein inhibited replication by 95%, compared to repli-
ation in the absence of C proteins, whereas C2 and
170S inhibited replication only 20 and 24%, respectively.
hese data show that the C2 and F170S mutations confer
FIG. 5. Effect of nonfusion C mutants on viral RNA synthesis. (A) In
vitro transcription. VVT7-infected cells were transfected with no plas-
mids (2) or with wt P, L, and the indicated wt or mutant C plasmids. Cell
extracts were prepared and incubated with wt RNA-NP in the presence
of [a-32P]CTP. RNA transcripts were isolated and analyzed by gel
lectrophoresis. The position of the NP and P transcripts is indicated.
B) In vitro replication. VVT7-infected cells were mock transfected (2) or
ransfected with plasmids encoding NP, P, L, and the indicated wt or
utant C proteins. Cytoplasmic extracts were incubated with DI-H
NA-NP in the presence of [a-32P]CTP, nuclease treated, and the
urified nucleocapsid RNA analyzed by gel electrophoresis. The posi-
ion of the DI-H RNA is indicated. In each panel the quantitation of the
ercentage inhibition was calculated relative to the control in the
(A) VVT7-infected cells were mock transfected (2) or transfected with
ding the wt NP, P, L, and the indicated wt or mutant gstC9 proteins.
-NP template in the presence of [a-32P]CTP, nuclease treated, and the
er Materials and Methods. The position of the DI-H RNA is indicated.
t (bottom) antibodies. The positions of P, NP, and gstC9 proteins are
MOYERcation.
e enco
I-H RNA
ed und
ANDbsence of C (set as 0% inhibition). The numbers shown are a result of
wo to three experiments with a variation of 610%.
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IBITIONa loss-of-function phenotype consistent with the results
obtained with the gst-fusion forms of the proteins.
Each of the wt C proteins binds to the L protein
Previous studies on the function of the Sendai C pro-
teins (C9, C, Y1, and Y2) in RNA synthesis were carried
out in the presence of all four, or various combinations, of
the C proteins (Cadd et al., 1996; Curran et al., 1992;
Tapparel et al., 1997). To address the question of their
ndividual functions, each C ORF was cloned down-
tream of the gst gene to encode the fusion proteins
stC9, gstC, gstY1, and gstY2. Analysis of in vitro protein
ynthesis in a coupled transcription–translation system
howed that translation initiated only at the AUG of gst,
ince no nonfusion proteins were synthesized from any
f the plasmids (data not shown). To test the ability of the
our fusion proteins to bind L, A549 cells were infected
ith VVT7 and mock transfected (2) or transfected with
he P and L plasmids in the absence or presence of the
stC9, gstC, gstY1, or gstY2 plasmids and labeled with
xpress-[35S] overnight. Immunoprecipitation of a portion
of the cytoplasmic cell extracts showed that compared to
the mock sample the P and L proteins were both ex-
pressed in the absence of fusion protein (Fig. 6A, lanes
1 and 2), but their expression was enhanced when co-
expressed with each fusion protein (lanes 3–6), as was
noted previously for gstC9 (Horikami et al., 1997). The C
fusion proteins were similarly expressed and showed
the expected decreases in size, with gstY2 being the
smallest protein. As a negative control for complex for-
mation in the absence of any viral proteins or with P and
L in the absence of fusion protein, there was little or no
protein bound to the glutathione beads as expected (Fig.
6B, lanes 1 and 2). As before, gstC9-bound L and P was
cobound because of the P–L interaction (Fig. 6B, lane 3).
Each of the other fusion proteins also bound the L pro-
tein, which was bound to P (Fig. 6B, lanes 4–6). The
results were normalized for their expression as deter-
mined by immunoprecipitation and quantitated as dis-
cussed above. The ratio of L:gstC9 was then set at 100%
(full binding), and the binding of the other fusion proteins
was 77% for gstC, 195% for gstY1, and 205% for gstY2
(Table 2). The amount of P protein cobound to the beads
corresponded exactly with the amount of L protein
bound. Thus all four C proteins were capable of binding
to Sendai L, with gstY1 and gstY2 exhibiting somewhat
greater binding in comparison to gstC9 and gstC.
Each of the wt C proteins inhibited viral RNA
synthesis in vitro
Since the four individual C proteins bound L, we next
tested if they functioned similarly with respect to the
inhibition of various aspects of viral RNA synthesis. For
VIRAL RNA SYNTHESIS INHthe analysis of mRNA synthesis in vitro, no plasmids (2),
or L and P in the absence or presence of the indicated Cfusion plasmids, were transfected into VVT7-infected
cells. Cytoplasmic cell extracts were prepared and incu-
bated with radiolabeled CTP and polymerase-free Sen-
dai nucleocapsids, and the RNA products analyzed by
gel electrophoresis. Compared with good transcription in
the absence of any C protein, the addition of gstC9, gstC,
gstY1, or gstY2, in each case similarly inhibited NP and P
mRNA synthesis, between 70 and 81% (Fig. 7A, Table 2).
The ability of the wt C fusion proteins to inhibit synthesis
of the first transcription product, the 55 nt le1RNA, was
also tested. Cytoplasmic extracts of infected, transfected
cells containing the P, L, and fusion C proteins were
prepared and incubated with Sendai RNA-NP template in
the absence of radiolabeled nucleotide. Total RNA was
FIG. 6. Complex formation between the gstC9, gstC, gstY1, and gstY2
proteins and the L protein. VVT7-infected cells were mock transfected
(2) or transfected with plasmids encoding the P, L, and gst-fusion
proteins as indicated above each lane. The cells were labeled with
Express-[35S] and cell extracts were (A) immunoprecipitated with a-L,
a-P, and a-gst antibodies; or (B) incubated with glutathione–Sepharose
beads and the immunoprecipitated and bead-bound proteins were
analyzed by SDS–PAGE. The positions of the L, P, and gst-fusion
proteins are indicated.
101BY SENDAI C PROTEINSisolated and le1 RNA synthesis was determined by
Northern blot analysis using an le1-specific oligonucle-
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1 ANDotide probe as described under Materials and Methods.
The P–L complex in the absence of C protein synthe-
sized full-length le1 product, which was not detected in
the absence of viral proteins (Fig. 7B, lanes 1 and 2). RNA
products longer than 55 nt were also detected and ap-
pear to be the result of readthrough of the leader-NP
gene junction as previously observed (Chandrika et al.,
1995; Vidal and Kolakofsky, 1989). In the presence of
gstC9, gstC, gstY1, or gstY2, le1 RNA synthesis was
nhibited between 82 and 92% (Fig. 7B, lanes 3–6; Table
). The small decrease in the amount of readthrough
roducts with gstY2 was not reproducible. Immunoblot
nalyses on a portion of the transcription extracts
howed that the four fusion proteins were expressed at
imilar levels (Figs. 7D and 7E). Thus gstC9, gstC, gstY1,
nd gstY2 were all similarly and independently able to
nhibit both le1 RNA and mRNA synthesis by the viral
olymerase.
To investigate the contribution of the individual C pro-
eins to the inhibition of antigenome replication, VVT7-
nfected cells were transfected with plasmids encoding
P, P, and L in the absence or presence of the wt C
usion plasmids. Cytoplasmic extracts were prepared
nd incubated with polymerase-free DI-H template and
a-32P]CTP and nuclease resistant, nucleocapsid-associ-
ted RNA products were analyzed by gel electrophore-
is. In the absence of C protein, full-length DI-H replica-
ion product was synthesized; however, in the presence
f gstC9, gstC, gstY1, and gstY2, replication was nearly or
ompletely inhibited (Fig. 7C, Table 2). Immunoblot anal-
ses of a portion of these extracts showed that the NP
nd P proteins were similarly expressed, and gstY1 and
stY2 were expressed somewhat more than gstC9 and
TABLE 2
Summary of L Binding and RNA Synthesis Inhibition
by the gstC Fusion Proteins
Mutant
L binding
(%)a
Inhibition (%)b
mRNA Le 1 RNA Replication
None 0 0 0 0
gstC9 100 70 82 93
gstC 77 69 89 99
gstY1 195 81 88 99
gstY2 205 79 92 99
a L binding of the mutants was expressed as a percentage of binding
f wt gstC9 to L as 100%, where the data are the average of two
xperiments with a deviation of 615%.
b mRNA and Le 1 RNA synthesis and DI-H replication in the absence
f any gstC9 protein was set as 100% synthesis, expressed as 0%
nhibition, and the data are the average of three to four experiments
ith a deviation of 610%.
02 GROGANstC (Fig. 7F). Thus these data indicate that the gstC9,
stC, gstY1, and gstY2 proteins were all capable of in-
b
pibiting multiple aspects of viral RNA synthesis indepen-
ently of one another.
onfusion C, Y1, and Y2 proteins similarly inhibit
ranscription
To ensure that the phenotypes observed with the Y1
nd Y2 fusion proteins were not due to any pleiotropic
ffect of the gst portion, the nonfusion C, Y1, and Y2
enes were cloned in the pTM1 vector as described
nder Materials and Methods. Western blot analysis of
xpression of these proteins in VVT7-infected, trans-
ected cells showed that quite different amounts of each
lasmid were required to achieve similar expression of
he proteins (Figs. 8A and 8B, bottom), so the transla-
ional efficiencies of the start sites are different. In these
onstructs, the C plasmid expressed C, but did not ex-
ress detectable amounts of Y1 and Y2, and the Y1
lasmid expressed Y1, but not Y2, presumably because
ranslation of the genes is under the control of an internal
ibosome binding site (IRES) in pTM1 and downstream
nitiation did not seem to occur. Extracts expressing
ncreasing amounts of each protein were tested for in-
ibition of viral mRNA synthesis in vitro. Compared to
RNA synthesis in the absence of any C protein, wt C
nhibited transcription by the viral polymerase by 60–
0%, while with Y1 inhibition at a protein concentration
imilar to C was 78% (Fig. 8A, lanes 4 and 6) and for Y2
as 44% (Fig. 8B, lanes 4 and 5). Increasing Y1 and Y2
ave further inhibition, although Y1 was always better
han Y2. Thus similar to the fusion forms of these pro-
eins, both Y1 and Y2 proteins gave inhibition of viral
RNA synthesis.
he C proteins similarly inhibited mRNA and leader
NA synthesis
During a naturally occurring virus infection, leader
NA is synthesized from both the genome and the anti-
enome RNA template, producing le1 RNA and le2
NA, respectively. Horikami et al. (1997) showed that the
ynthesis of le2 RNA by the viral polymerase from the
I-H template in vitro was inhibited by the C proteins;
owever, this inhibition required a much higher level of
rotein than was necessary for the inhibition of full-
ength replication product from the same template. It was
f interest, therefore, to determine whether C proteins
lso gave a differential effect on le1 RNA and mRNA
ynthesis from Sendai wt RNA-NP template. A549 cells
ere infected in duplicate with VVT7 and then trans-
ected with the P and L plasmids, and increasing
mounts of wt C plasmid, which expressed all four C
roteins. The cytoplasmic extracts were pooled and
qual samples were assayed for mRNA and le1 RNA
ynthesis in vitro. Compared to the synthesis of le1 RNA
MOYERy the P–L polymerase, increasing amounts of the C
roteins increasingly inhibited le1 RNA synthesis (Fig.
C
(
a
a
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p
gel ele
samp
a cts fro9A). Inhibition of in vitro mRNA synthesis with increasing
proteins also occurred in a dose-dependent manner
Fig. 9B). The amount of RNA synthesis was quantitated
s a percentage of each product synthesized in the
bsence of any C protein, and the data show there was
nearly identical dose dependence of inhibition by the C
roteins for both le1 RNA and for mRNA synthesis (Fig.
9C). These data suggest that the C proteins are specif-
ically affecting Sendai RNA synthesis at an early step.
DISCUSSION
The Sendai virus C9 protein has been shown to spe-
FIG. 7. Each of the four wt gstC proteins can inhibit viral RNA synthe
plasmids (2) or with P, L, and gst (none), or with P, L and the indicated
wt RNA-NP and [a-32P]CTP and the RNA transcripts were isolated and
indicated. (B) le1 RNA synthesis. VVT7-infected cells were transfected
analyzed by Northern blot with a complementary end-labeled probe de
xylene cyanol (XC) dye are indicated. (C) In vitro replication. VVT7-infe
plasmids or with NP, P, L and the indicated gst-fusion plasmids. Cytopla
nuclease treated, and the nucleocapsid-associated RNA analyzed by
Immunoblot analyses with a-P (top) and a-gst antibodies (bottom) on
nalyses with a-SV and a-P (top) and a-gst (bottom) antibodies on extra
VIRAL RNA SYNTHESIS INHcifically bind the L protein (Horikami et al., 1997) and to
downregulate viral RNA synthesis (Cadd et al., 1996;Curran et al., 1992; Horikami et al., 1997; Tapparel et al.,
1997). To test if there is a relationship between binding
and inhibition, we wanted to identify the essential amino
acids in C9 by site-directed mutagenesis of gstC9. A
summary of the functions of mutants of C9 (Table 1)
showed that three noncontiguous mutants, gstC91,
gstC97, and gstC99, retained nearly wt binding and inhi-
bition, so these amino acids are nonessential. For six
other mutants there was in fact a direct correlation be-
tween the loss of L binding and the loss of inhibition of
transcription and antigenome replication, suggesting
that the two are directly linked. GstC93 was the excep-
In vitro mRNA synthesis. VVT7-infected cells were transfected with no
sion plasmid. Cytoplasmic extracts were prepared and incubated with
ed by gel electrophoresis. The position of the NP and P transcripts is
(A); extracts incubated with wt RNA-NP and le1 RNA synthesis were
under Materials and Methods. The positions of le1 RNA (55 nt) and
lls were mock transfected (2) or cotransfected with NP, P, L, and gst
tracts were incubated with DI-H RNA-NP in the presence of [a-32P]CTP,
ctrophoresis. The position of the DI-H RNA is indicated. (D) and (E)
les of the extracts from (A) and (B), respectively, and (F) immunoblot
m (C). The positions of the NP, P, and gst-fusion proteins are indicated.
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( s of thespectively, compared to wt gstC9. This implies that just
the binding of C to L is not sufficient for inhibition of the
polymerase, since the two functions can be separated. A
similar correlation between binding and inhibition was
also observed with the nonfusion form of several of the
C9 mutants (Fig. 5), showing that the gst portion of the
gst-tagged fusion proteins was not contributing to, or
interfering with, the results.
Despite one report which suggested that P protein over-
expression overcame C inhibition of RNA synthesis (Tap-
parel et al., 1997), the data here show that it is L binding that
is important for C inhibition. Perhaps this is an indirect
effect where the overexpression of P changes the confor-
mation of L so that it can no longer bind C. Since L must
also bind P, there probably is a very precise ratio of the
proteins required for the regulation and synthesis of viral
RNA. The mutagenesis strategy for C9 was to replace clus-
tered charged amino acids with alanine. The five sites of
alanine mutations in C92, C94–6, and C98 that decreased
inding were not contiguous and located from amino acids
8 to 187 of the 215 amino acid protein. These data suggest
hat the L binding site on C9 is a nonlinear, hydrophilic
urface created by the folding of the protein. F170S, which
lso decreased both functions, is located 3 amino acids
oward the N-terminus from C98. With the exception of
stC91, the altered Sendai amino acids are virtually identical
o those in the C proteins of PIV1 and PIV3. This suggests
hat these same amino acids will also be important for C
unction in these viruses.
We also wanted to address the question of whether
he wt C9, C, Y1, and Y2 proteins all have similar func-
ions, since there was earlier conflicting data about
hether they could substitute for each other (Kurotani et
FIG. 8. Nonfusion C, Y1, and Y2 proteins inhibit viral transcription.VV
ndicated amounts (mg) of the nonfusion C, Y1, or Y2 plasmids. Cytopla
f [a-32P]CTP and (top) RNA transcripts were isolated and analyzed b
Bottom) Immunoblot analysis with a-P and a-C antibodies on sample
104 GROGANl., 1998; Latorre et al., 1998a). The C proteins are all
expressed in the same ORF, so it has been difficult toablate expression of one protein without affecting the
expression of the others. The N-terminal gst fusions with
C9, C, Y1, and Y2 used here restricted expression to one
protein and we showed that each similarly bound the L
protein and inhibited various aspects of in vitro RNA
synthesis (Table 2). This was confirmed with the nonfu-
sion forms of the proteins (Fig. 8). Since all the amino
acids that we identified by mutagenesis as important for
C function are located downstream of the Y2 transla-
tional start site, they are found in all four C proteins. Thus
we predicted that they would have similar functions as
we observed. It is not clear why a previous study (Latorre
et al., 1998a) in a similar system showed no inhibition by
Y1 and Y2. Perhaps it is related to different levels of
protein expression since different expression vectors
were used in the present study. Moreover, a recent report
using cell lines expressing each protein has also con-
firmed that Y1 and Y2 function similar to C to inhibit all
viral RNA synthesis in vivo (Kato et al., 2001). Our results
show inhibition of in vitro RNA synthesis by Y1 and Y2
and show that their function is related to the ability of the
proteins to bind L protein.
The four C proteins are functionally equivalent also in
their ability to overcome the IFN-mediated response.
Gotoh et al. (1999) showed that a C9/C(2) knockout virus,
which expressed Y1 and Y2, was able to downregulate
the IFN-mediated response like wt virus, but a 4C(2)
knockout virus had lost this function. Y1 and Y2 in con-
stitutively expressing cells lines were also shown di-
rectly to inhibit the interferon responses (Kato et al.,
2001). Another function of the C proteins is to mediate
assembly of structural proteins into virions and this prop-
erty is independent of the anti-interferon activity of the
cted cells were transfected with no plasmids (2) or with P, L, and the
xtracts were prepared and incubated with wt RNA-NP in the presence
lectrophoresis. The position of the NP and P transcripts is indicated.
extracts. The positions of the P and C proteins are indicated.
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ANDprotein (Hasan et al., 2000).
The nearly identical correlation between dose-depen-
e
h
v
d
r
t
a
l
c
t
R
e
i
t
t
l
g
o
e
p
(
w NA prodent inhibition by the C proteins on le1 RNA and mRNA
synthesis (Fig. 9D) suggests that the C–L–P polymerase
complex is affected at an early stage of viral RNA syn-
thesis. In contrast, Horikami et al. (1997) showed that
inhibition of (2)-leader RNA required more C protein
than was needed to inhibit full-length genome DI-H rep-
lication, indicating that replication was more sensitive to
C inhibition than (2)-leader synthesis from the same
template. These data are in agreement with previous
studies showing that C-mediated inhibition of RNA syn-
thesis was promoter-specific (Cadd et al., 1996; Tapparel
t al., 1997). It is not clear, however, with the DI template
ow the initiation step, approximated by le2 synthesis,
s elongation as measured by full-length product, are
ifferentially inhibited. Perhaps it suggests that L in a
FIG. 9. The C proteins inhibit in vitro mRNA and le1 RNA synthes
plasmid (2) or cotransfected with the wt P and L plasmids, in the absen
were pooled and samples assayed in vitro for (A) le1 RNA synthesis an
XC) dye (A) and the location of the NP and P transcripts (B) are indicate
ere quantitated using a phosphorimager and expressed relative to R
VIRAL RNA SYNTHESIS INHeplicase mode is different from L as a transcriptase.
While the data presented here suggest that the C pro-
c
Ceins are inhibiting viral RNA synthesis through their inter-
ction with the L protein, the molecular mechanism under-
ying this effect is still unclear. The binding of the C proteins
ould alter the ability of the viral polymerase to recognize
he 39 end of the nucleocapsid template when initiating
NA synthesis. The sequence of the leader genes at the 39
nd of the genome and antigenome are similar, but not
dentical, with sequence complementarity extending only
hrough the first 12 nt (Galinski, 1991; Pelet et al., 1996). If
emplate recognition is dictated through recognition of at
east some sequences downstream of the conserved re-
ion in the leader gene, it could follow that in the presence
f C the polymerase recognizes the two promoters differ-
ntly. Perhaps C affects the structure or folding of the L
rotein during polymerase formation to give promoter-spe-
arly. VVT7-infected cells were transfected in duplicate with either no
resence of increasing amounts of the C plasmid. Cytoplasmic extracts
RNA synthesis. The position of the 55-nt le1 product and xylene cyanol
raphic representation of the data where le1 RNA and mRNA products
duct synthesized in the absence of any C proteins (set as 100%).
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ANDeffect (Curran et al., 1992). Indeed P protein apparently
functions to stabilize and properly fold the L protein
(Horikami et al., 1992, 1997).
The amino acid substitution F170S in the C ORFs has
been associated with significant virus attenuation in in-
fection of mice (Cadd et al., 1996; Garcin et al., 1997; Itoh
t al., 1998, 1997). In accordance with our hypothesis that
he C proteins inhibit the viral polymerase through inter-
ction with the L protein, it might have been predicted
hat gstF170S would show more severe defects in bind-
ng and inhibition than it did in vitro (Table 1). However,
t might not be surprising that gstF170S retained some
inding to the L protein and correspondingly retained
ome inhibitory function, since Kurotani et al. (1998)
found that 4C2 knockout virus was critically impaired for
growth. Clearly the C proteins play an essential role in
the viral life cycle. Pathogenesis in animals is probably
due to a combination of the functions of the C proteins in
regulating RNA synthesis, virion assembly, and interferon
responses, not just to one C function.
MATERIALS AND METHODS
Cells, viruses, plasmids, and antibodies
Human lung carcinoma cells (A549 cells, ATCC) were
used for all experiments. Recombinant vaccinia virus
expressing the phage T7 RNA polymerase (VVT7) (Fuerst
et al., 1986) was grown on CV1 cells. Sendai virus and
the Sendai virus defective interfering particle (DI-H) were
propagated on embryonated chicken eggs and wild-type
polymerase-free Sendai and DI-H templates were pre-
pared as described previously (Carlsen et al., 1985).
lasmids encoding the Sendai virus genes, pGEM-L,
GEM-NP, and pGEM-Pstop (expressing only the P pro-
ein), were described previously (Curran et al., 1991). The
pGEM-C plasmid, which expresses the four C proteins
(C9, C, Y1, and Y2) but not P, and pTM1gstC9 were
escribed previously (Horikami et al., 1997). The genes
ere all cloned downstream of the phage T7 RNA poly-
erase promoter. Primary antibodies utilized for immu-
oblot and immunoprecipitation assays were as follows:
abbit polyclonal anti-Sendai virus antibody (a-SV)
Carlsen et al., 1985), rabbit polyclonal anti-L protein
antibody (a-L) (Smallwood et al., 1994), rabbit polyclonal
ntibody specific for the P peptides of aa 274–298 and aa
53–477 (a-P, provided by Dr. K. Gupta, Rush Medical
ollege, Chicago, IL) (Byrappa et al., 1995), rabbit poly-
lonal anti-C antibody (a-C) specific for peptides found in
all four of the C proteins (provided by Dr. K. Gupta, Rush
Medical College, Chicago, IL), and rabbit polyclonal an-
tiglutathione S-transferase antibody (a-gst) (Chandrika et
al., 1995).
utagenesis
106 GROGANCharged-to-alanine mutagenesis of pTM1gstC9 was
arried out using a PCR-based mutagenesis strategy
r
Pwith Vent polymerase (NEB) (Higuchi et al., 1988). This
method employs a two-step PCR with complementary
mutagenesis primers which also contained a new silent
restriction site for screening purposes (sequences avail-
able upon request). The first round contained a muta-
genic primer and the appropriate upstream (BamHI con-
taining) or downstream (XhoI containing) outside primer,
generating two partially complementary DNAs. The sec-
ond round used the two DNAs and the two outside
primers, generating a full-length mutant PCR product that
was digested with BamHI and XhoI and cloned into
pTM1gstC9 at these sites. Two nonfusion C mutants
were also constructed in a similar manner in the plasmid
pGEM-C to create proteins without the gst tag. The
resulting plasmids, pGEM-C2 and pGEM-F170S, each
expressed the four C proteins which all contained the
mutation. The mutations were confirmed by sequencing
the entire C9 gene. Gst-tagged fusion forms of the C, Y1,
and Y2 proteins were constructed by PCR of each indi-
vidual ORF from pTM1gstC9 using 59 primers specific for
the start site of each protein and a common 39 primer
specific for the stop site of the C proteins. The three
upstream primers contained a BamHI linker, and the
downstream primer contained an XhoI linker. The PCR
products were digested with BamHI and XhoI and cloned
into pTM1gst at those sites, fusing the ORF downstream
and in-frame with gst, creating pTM1gstC, pTM1gstY1,
and pTM1gstY2. To construct the nonfusion C, Y1, and Y2
plasmids, pTM1gstC, pTM1gstY1, and pTM1gstY2 were
cut with BamHI and XhoI to release the C, Y1, and Y2
genes, respectively, which were cloned into those sites
in pTM1.
Protein analysis
A549 cells in 35-mm dishes were infected with VVT7 at
an m.o.i. of 2.5 PFU/cell for 1 h at 37°C. Cells were then
transfected with pGEM-Pstop (1.67 mg), pGEM-L (1.67
mg), and the wt or mutant pTM1gstC9 (0.1 mg) using
lipofectin (Life Technologies) according to the manufac-
turer’s protocol in Opti-MEM (GIBCO). Four hours post-
transfection (p.t.), cells were labeled with Express-[35S]
100 mCi/ml, DuPont NEN) with 0.13 cysteine and methi-
nine. Cytoplasmic extracts were prepared at 18 h p.t. by
craping into 165 ml SV Salts [0.1 M HEPES (pH 8.5), 0.05
NH4Cl, 7 mM KCl, and 4.5 mM MgOAc, and 1 mg/ml
aprotinin] and 0.25% Nonidet P-40 (NP-40). The cell ly-
sate was clarified by pelleting for 30 min at 13,000 rpm
and samples (70 ml) were used for immunoprecipitation
nd bead-binding. For immunoprecipitation, the extracts
ere incubated with the appropriate primary antibodies
1 ml each a-P, a-L, and a-gst; see figure legends) for 1 h
at 4°C and Staphylococcus aureus (Cowain strain) was
hen added. The immunocomplexes bound to the bacte-
MOYERia were pelleted, washed, and separated by 7.5% SDS–
AGE (Horikami et al., 1992). For bead-binding analysis,
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total volume of 450 ml. Blocked glutathione–Sepharose
4B beads (15 ml per sample; Pharmacia Biotech) were
incubated with extracts for 15 min at 4°C, pelleted, and
washed 33 in 800 ml SV Salts 1 0.25% NP-40. The
roteins were separated by 7.5% SDS–PAGE, visualized
y autoradiography, and quantitated on the phosphorim-
ger.
For immunoblot analysis, cell extracts used for RNA
ynthesis were separated by 10% SDS–PAGE and elec-
roblotted onto nitrocellulose. To avoid antibody cross-
eactivity, the extracts were divided in half and run on two
eparate gels. One blot was then incubated with a-P to
etect P protein in transcription assays, with the addition
f an a-SV to detect NP in replication assays. The other
blot was probed with a-gst to detect the gstC9 fusion
proteins. For expression of the nonfusion C proteins, the
blots were incubated with both a-C and a-P antibodies.
The blots were developed with conjugated goat anti-
rabbit secondary antibody using the enhanced chemilu-
minescence (ECL) protein identification system (Amer-
sham Life Science) according to the manufacturer’s pro-
tocol. Since the C mutants without the gst tag could not
be detected with the a-C antibody, [3H]leucine-labeled C
protein expression from plasmids was quantitated using
the TNT Coupled Reticulocyte Lysate System (Promega).
The proteins were separated by 10% SDS–PAGE and
visualized by autoradiography.
In vitro RNA synthesis
For transcription assays, 60-mm dishes of A549 cells
were infected with VVT7 and transfected with Pstop (1.5
mg), L (0.5 mg), and the wt or mutant gstC9 (0.2 mg) or C
(2 mg) plasmids as indicated. For in vitro replication,
Pstop (5 mg), L (0.5 mg), NP (2 mg), and the wt or mutant
stC9 (0.2 mg) or C (2 mg) plasmids were transfected. The
mounts of the different C plasmids added were titrated
o be in the linear range for the inhibition of RNA syn-
hesis. To ensure constant DNA in transfection, plasmid
ncoding the gst protein (pTM1gst, 0.2 mg) was included
n all transfections where no gst-fusion plasmid was
resent, and pGEM4 was included where no pGEM-C
as present. At 18 h p.t. cell extracts (100 ml) were
prepared by lysolecithin permeabilization in SV Incom-
plete Reaction Mix (RM) [0.1 M HEPES (pH 8.5), 50 mM
NH4Cl, 7 mM KCl, 4.5 mM MgOAc, 1 mM DTT, 1 mM
permidine, 1 mM each ATP, GTP, and UTP, 10 mM CTP,
and 10% glycerol] as described previously (Chandrika et
al., 1995; Horikami et al., 1992). A portion of extract (10%)
as removed for immunoblotting and the remainder was
sed for RNA synthesis. For in vitro mRNA and le1 RNA
ynthesis, the cell extracts were incubated with 20 mg/ml
icrococcal nuclease (MN) plus 1 mM CaCl2 at 30°C for
VIRAL RNA SYNTHESIS INH30 min, followed by 2.2 mM EGTA for inactivation of the
MN. For mRNA synthesis, the nuclease-treated extractswere then supplemented with 0.1 vol of 103 supplemen-
al mix [45 mM MgOAc, 5 U/ml RNasin, 200 mg/ml acti-
omycin D, 400 U/ml creatine phosphokinase (CPK), and
3 mg/ml creatine phosphate], 1 mg polymerase-free wt
endai nucleocapsid template (RNA-NP), and 20 mCi of
[a-32P]CTP. The samples were incubated for 2 h at 30°C,
RNA then isolated using Qiagen RNeasy Total RNA kit
according to the manufacturer’s protocol, and analyzed
by 1.5% agarose/6 M urea–citrate gel electrophoresis.
The RNA was visualized by autoradiography and quan-
titated using a phosphorimager.
Leader RNA synthesis was performed as described for in
vitro mRNA synthesis with polymerase-free wt template (2.5
mg), except the cell extracts were prepared in SV incom-
plete RM with 1 mM CTP without radiolabeled CTP. The
incubated samples were then treated with proteinase K and
extracted with phenol/chloroform; the RNA was separated
on a 8% polyacrylamide/8 M urea gel and electroblotted
onto Hybond N nylon (Amersham). Le1 RNA was detected
by Northern blot analysis using a complementary 32P end-
abeled 55-nt oligonucleotide probe (59AAATCCTGTA TA-
CTTCATT ACATATCCCA TACATGTTTT TTCTCTTGTT
GGT39) as described previously (Horikami and Moyer,
995).
Extracts for in vitro replication were prepared using
ysolecithin permeabilization in SV Incomplete RM sup-
lemented with 4.5 mM MgOAc and 0.5 U/ml RNasin.
Actinomycin D (20 mg/ml), 50 mCi [a-32P]CTP, and 2 mg
polymerase-free DI-H RNA-NP were added to the sam-
ples and incubated for 2 h at 30°C. The samples were
then MN treated; nuclease-resistant RNA was isolated
using the Qiagen RNeasy Total RNA kit and analyzed by
electrophoresis on a 1.5% agarose/6 M urea–citrate gel.
The RNA was visualized by autoradiography and quan-
titated using a phosphorimager.
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